Results 61 to 70 of about 239 (122)

EFICACIA DE LA DEXAMETASONA EN SINDROME HELLP

open access: yesRevista Chilena de Obstetricia y Ginecología, 2003
Después de la administración de dexametasona (vía EV en dosis de 10 mg. cada 12 horas) a una paciente de 26 semanas de gestación, hipertensa crónica con preeclampsia sobreagregada y síndrome Hellp, se aprecia estabilización y disminución de enzimas ...
Ramón Almuna V.   +5 more
doaj  

Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia. [PDF]

open access: yesRev Bras Ginecol Obstet, 2021
Nunes PR   +7 more
europepmc   +1 more source

ESPECTRO CLÍNICO DE LA PREECLAMPSIA: ESTUDIO COMPARATIVO DE SUS DIVERSOS GRADOS DE SEVERIDAD

open access: yesRevista Chilena de Obstetricia y Ginecología, 2007
Objetivo: Comparar los resultados maternos y perinatales en embarazadas que cursaron con preeclampsia (PE) en sus diversas presentaciones en el período 2001 -2005.
Mauro Parra C   +8 more
doaj  

Recurrent preterm birth: data from the study "Birth in Brazil". [PDF]

open access: yesRev Saude Publica, 2022
Dias BAS   +5 more
europepmc   +1 more source

Update on Thrombocytopenia in Pregnancy. [PDF]

open access: yesRev Bras Ginecol Obstet, 2020
Subtil SFC   +3 more
europepmc   +1 more source

Nursing care for women with HELLP syndrome: a scoping review. [PDF]

open access: yesRev Esc Enferm USP
Arduini PS   +3 more
europepmc   +1 more source

Position Statement on Exercise During Pregnancy and the Post-Partum Period - 2021. [PDF]

open access: yesArq Bras Cardiol, 2021
Campos MDSB   +12 more
europepmc   +1 more source

[Early preeclampsia associated with hydatidiform mole and pulmonary metastasis: A case report]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Rivera-Hernández DA   +3 more
europepmc   +1 more source

Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. [PDF]

open access: yesSao Paulo Med J, 2006
Osmanagaoglu MA   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy